{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:02:26Z","timestamp":1793142146507,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is recognised as a potential risk factor for chronic non communicable diseases (NCD). Although international guidelines recommend proactive NCD risk prevention, actual practice may be suboptimal. This study aimed to identify unmet clinical needs regarding information, risk assessment and satisfaction with care related to NCD risk factors among women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An eight-domain questionnaire was developed based on the 2018 ESHRE guideline, covering demographics, PCOS diagnostic criteria, aesthetics, metabolism, reproduction, mental health and NCD prevention \/monitoring. The present analysis focused on metabolic disorders, guideline-recommended risk screenings, patients\u2019 satisfaction with care and overall satisfaction with management by healthcare providers (HCPs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2029 respondents, 1943 answered metabolic-related items. 66.3% without known metabolic disease (MD) reported never having undergone screening for MD. 34.3% received advice from gynaecologist, 58.9% from general practitioner (GP) concerning MD. 41.1% (n\u2009=\u2009271) did not receive counselling. Among 1839 respondents, 32.5% reported gynaecologist-led risk discussions. Annual screening occurred in 30.5% (body weight), 46.8% (blood pressure), 5.8% (gynaecologist) to 21.4 (GP) for serum cholesterol and 25.4% for diabetes. 1.0% had been consulted on obstructive sleep apnoea (OSA), 17.5% on endometrial cancer. Satisfaction with gynaecologist counselling was low (Mean 34.7), 79.4% expressed a desire for more advice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Women with PCOS remain at high risk for NCDs (CVD, diabetes, endometrial cancer, OSA), yet experience substantial gaps in risk awareness, monitoring, and counseling. Addressing these deficiencies through improved clinical practice, education and adopting holistic PCOS management that balances NCD prevention with infertility concerns, is essential for safeguarding long-term health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-025-08287-x","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:24:46Z","timestamp":1767871486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unmet clinical needs in women with polycystic ovary syndrome regarding chronic non-communicable diseases: A cross\u2011sectional study"],"prefix":"10.1007","volume":"313","author":[{"given":"Susanne","family":"Theis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8682-2082","authenticated-orcid":false,"given":"Elena","family":"Pavicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Estermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Bitterlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Fr\u00fchwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Stute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"5","key":"8287_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1631\/jzus.B1700074","volume":"19","author":"F-F Wang","year":"2018","unstructured":"Wang F-F et al (2018) American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis. J Zhejiang Univ-Sci B 19(5):354\u2013363","journal-title":"J Zhejiang Univ-Sci B"},{"issue":"2","key":"8287_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2009","unstructured":"March WA et al (2009) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25(2):544\u2013551","journal-title":"Hum Reprod"},{"issue":"3","key":"8287_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"310","author":"N Salari","year":"2024","unstructured":"Salari N et al (2024) Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet 310(3):1303\u20131314","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"8287_CR4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","volume":"87","author":"E Hollinrake","year":"2007","unstructured":"Hollinrake E et al (2007) Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 87(6):1369\u20131376","journal-title":"Fertil Steril"},{"issue":"6","key":"8287_CR5","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18(6):774\u2013800","journal-title":"Endocr Rev"},{"key":"8287_CR6","doi-asserted-by":"crossref","unstructured":"Sirmans SM, Pate KA (2013) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical epidemiology, p. 1\u201313.","DOI":"10.2147\/CLEP.S37559"},{"issue":"9","key":"8287_CR7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 33(9):1602\u20131618","journal-title":"Hum Reprod"},{"issue":"9","key":"8287_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","volume":"38","author":"HJ Teede","year":"2023","unstructured":"Teede HJ et al (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020. Hum Reprod 38(9):1655\u20131679","journal-title":"Hum Reprod"},{"issue":"694","key":"8287_CR9","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.3399\/bjgp20X708881","volume":"70","author":"SC Hillman","year":"2020","unstructured":"Hillman SC et al (2020) Women\u2019s experiences of diagnosis and management of polycystic ovary syndrome: a mixed-methods study in general practice. Br J Gen Pract 70(694):e322\u2013e329","journal-title":"Br J Gen Pract"},{"issue":"4","key":"8287_CR10","doi-asserted-by":"publisher","DOI":"10.2196\/16541","volume":"22","author":"LR Hoyos","year":"2020","unstructured":"Hoyos LR et al (2020) Measures of patient dissatisfaction with health care in polycystic ovary syndrome: retrospective analysis. J Med Internet Res 22(4):e16541","journal-title":"J Med Internet Res"},{"issue":"11","key":"8287_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/jwh.2022.0497","volume":"32","author":"J Estermann","year":"2023","unstructured":"Estermann J et al (2023) Unmet clinical needs in women with aesthetic manifestations of polycystic ovary syndrome: a cross-sectional study. J Womens Health (Larchmt) 32(11):1241\u20131248","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"8287_CR12","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00404-024-07452-y","volume":"309","author":"M Sourouni","year":"2024","unstructured":"Sourouni M et al (2024) Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study. Arch Gynecol Obstet 309(5):2115\u20132126","journal-title":"Arch Gynecol Obstet"},{"key":"8287_CR13","unstructured":"AWMF, D.G.f.E.e.V. S2k-Leitlinie Diagnostik und Therapie des polyzystischen Ovarsyndroms (PCOS). 2024 [cited 2025 24.10.2025]; Available from: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/register.awmf.org\/assets\/guidelines\/089-004k_S2k_Diagnostik-Therapie-polyzystisches-Ovarsyndrom-PCOS_2025-08.pdf."},{"issue":"8","key":"8287_CR14","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/deac091","volume":"37","author":"S Safiri","year":"2022","unstructured":"Safiri S et al (2022) Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990\u20132019. Hum Reprod 37(8):1919\u20131931","journal-title":"Hum Reprod"},{"issue":"12","key":"8287_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF et al (2015) AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocr Pract 21(12):1415\u20131426","journal-title":"Endocr Pract"},{"issue":"16","key":"8287_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033572","volume":"13","author":"CT Tay","year":"2024","unstructured":"Tay CT et al (2024) 2023 International Evidence\u2010Based Polycystic Ovary Syndrome Guideline Update: insights from a systematic review and meta\u2010analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome. J Am Heart Assoc 13(16):e033572","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"8287_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00404-024-07916-1","volume":"311","author":"A Bachmann","year":"2025","unstructured":"Bachmann A et al (2025) Unmet clinical needs in women with polycystic ovary syndrome regarding fertility and obesity: a cross-sectional study from the patient\u2019s perspective. Arch Gynecol Obstet 311(3):851\u2013859","journal-title":"Arch Gynecol Obstet"},{"issue":"22","key":"8287_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40431","volume":"10","author":"K Hofmann","year":"2024","unstructured":"Hofmann K et al (2024) Gaps in knowledge regarding the diagnostic criteria and management of PCOS in Germany: an anonymous web-based survey. Heliyon 10(22):e40431","journal-title":"Heliyon"},{"issue":"1","key":"8287_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12905-022-01734-w","volume":"22","author":"M Ismayilova","year":"2022","unstructured":"Ismayilova M, Yaya S (2022) What can be done to improve polycystic ovary syndrome (PCOS) healthcare? Insights from semi-structured interviews with women in Canada. BMC Womens Health 22(1):157","journal-title":"BMC Womens Health"},{"issue":"2","key":"8287_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","volume":"107","author":"C Riestenberg","year":"2022","unstructured":"Riestenberg C et al (2022) Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab 107(2):575\u2013585","journal-title":"J Clin Endocrinol Metab"},{"key":"8287_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.85338","author":"S Yadav","year":"2023","unstructured":"Yadav S et al (2023) Direct economic burden of mental health disorders associated with polycystic ovary syndrome: systematic review and meta-analysis. Elife. https:\/\/doi.org\/10.7554\/eLife.85338","journal-title":"Elife"},{"issue":"1","key":"8287_CR22","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1210\/clinem\/dgae527","volume":"110","author":"L Pace","year":"2024","unstructured":"Pace L et al (2024) Economic burden of endometrial cancer associated with polycystic ovary syndrome. J Clin Endocrinol Metab 110(1):e168\u2013e176","journal-title":"J Clin Endocrinol Metab"},{"issue":"36","key":"8287_CR23","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.2174\/1381612822666160720151243","volume":"22","author":"S Poli Mara","year":"2016","unstructured":"Poli Mara S, Rocha BC, Bazanella de OF (2016) Hirsutism in polycystic ovary syndrome: pathophysiology and management. Curr Pharm Des 22(36):5603\u20135613","journal-title":"Curr Pharm Des"},{"issue":"5","key":"8287_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/09513590.2020.1859474","volume":"37","author":"F Ramezani Tehrani","year":"2021","unstructured":"Ramezani Tehrani F et al (2021) Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecol Endocrinol 37(5):392\u2013405","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"8287_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejogrb.2010.07.015","volume":"152","author":"A Sharma","year":"2010","unstructured":"Sharma A, Walker D-M, Atiomo W (2010) National survey on management of weight reduction in PCOS women in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 152(2):181\u2013185","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08287-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08287-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08287-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:02:13Z","timestamp":1767916933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08287-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8287"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08287-x","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Cantonal Ethics Committee Bern (Req-2020\u201300801) has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study highlights the need for regular risk assessments and improved patient education for women with PCOS, who show a strong willingness to engage in their care. It also calls for greater awareness among healthcare professionals to ensure comprehensive, guideline-based management and improved long-term outcomes.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"What does this study add to the clinical work?"}}],"article-number":"21"}}